Ki-67 Protein Expression in Smokeless Tobacco (Maras Powder)-Induced Oral Mucosal Lesions

REFERENCES

• Erenmemişoğlu A., Tekol Y., Kartal M., Kurucu S. Abuse of smokeless tobacco in Turkey “Maraş powder.” Doğa. Tr. J. Med. Sci. 1992; 16: 867–876
   Google Scholar
• Gonzalez-Moles M. A., Ruiz-Avila I., Rodriguez-Archilla A., Martinez-Lara I. Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia. Head Neck 2000; 22: 658–661
   PubMed Web of Science ®Google Scholar
• Grady D., Greene J., Daniels T. E., Ernster V. L., Robertson P. B., Hauck W. Oral mucosal lesions found in smokeless tobacco users. J. Am. Dent. Assoc. 1990; 121: 117–123
   PubMed Web of Science ®Google Scholar
• Hoffman D., Djordjevic M. V. Chemical composition and carcinogenicity of smokeless tobacco. Adv. Dent. Res. 1997; 11: 322–329
   PubMedGoogle Scholar
• Hong M. K., Laskin W. B., Herman B. E., Johnston M. H., Vargo J. J., Steinberg S. M., Allegra C. J., Johnston P. G. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 1995; 75: 423–429
   PubMed Web of Science ®Google Scholar
• Ibrahim S. O., Johannessen A. C., Idris A. M., Hirsch J. M., Vasstrand E. N., Magnusson B. Immunohistochemical detection of p53 in non-malignant and malignant oral lesions associated with snuff dipping in the Sudan and Sweden. Int. J. Cancer 1996; 68: 749–753
   PubMed Web of Science ®Google Scholar
• Idria A. M., Ahmed H. M., Mukhtar B. I., Gadir A. F., El-besheir E. N. Descriptive epidemiology of oral neoplasms in the Sudan, 1970–1985 and the role of toombak. Int. J. Cancer 1995; 60: 1–4
   PubMedGoogle Scholar
• Idris A. M., Ibrahim S. O., Vasstrand E. N., Johannessen A. C., Lillehaug J. R., Magnusson B., Wallstrom M., Hirsch J. M., Nilsen R. The Swedish snus and the Sudanese toombak: are they different?. Oral Oncol. 1998; 34: 558–566
   PubMed Web of Science ®Google Scholar
• Idris A. M., Warnakulasuriya K. A. A. S., Ibrahim Y. E., Nilsen R., Copper D., Johnson N. V. Toombak-associated oral mucosal lesions in Sudanese show a low prevalence of epithelial dysplasia. J. Oral Pathol. Med. 1996; 25: 239–244
   Web of Science ®Google Scholar
• Kushner J., Bradley G., Jordan R. C. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth. J. Pathol. 1997; 183: 418–423
   PubMed Web of Science ®Google Scholar
• Lumerman H., Freedman P., Kerpel S., Flushing N. Y. Oral epithelial dysplasia and the development of invasive squamous cell cacinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1995; 79: 321–329
   PubMed Web of Science ®Google Scholar
• Martinez-Lara I., Gonzales-Moles M. A., Ruiz-Avila I., Bravo M., Ramos M. C., Fernandez-Martinez J. A. Proliferating cell nuclear antigen (PCN) as a marker of dysplasia in oral mucosa. Acta Stomatol. Belg. 1996; 93: 29–32
   PubMedGoogle Scholar
• Merne M., Heinaro I., Lahteenoja H., Syrjanen S. Proliferation and differentiation markers in snuff-induced oral mucosal lesions. J. Oral Pathol. Med. 2002; 31: 259–266
   PubMed Web of Science ®Google Scholar
• Murrah V. A., Gilchrist E. P., Moyer M. P. Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture. Oral Surg. Oral Med. Oral Pathol. 1993; 75: 323–332
   PubMedGoogle Scholar
• Okuno Y., Nishimura Y., Kashu I., Ono K., Hiraoka M. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of esophageal squamous cell carcinoma. Br. J. Cancer 1999; 80: 387–395
   PubMed Web of Science ®Google Scholar
• Oestman J., Anneroth G., Gustafsson H., Tavelin B. Malignant oral tumors in Sweden 1960–1989 epidemiological study. Oral Oncol. Eur. J. Cancer 1995; 31B: 106–112
   PubMed Web of Science ®Google Scholar
• Reichard P. A., Schmidt-Westhausen A., Theetranont C. Oral cancer in Northern Thailand. Exp. Pathol. 1990; 40: 229–231
   PubMedGoogle Scholar
• Rodu B., Cole P. Smokeless tobacco use and cancer of the upper respiratory tract. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2002; 93: 511–515
   PubMed Web of Science ®Google Scholar
• Salem G., Juhl R. Oral malignant and premalignant changes in shamma users from The Gizan region, Saudi Arabia. Acta Odontol. Scand. 1984; 42: 41–45
   PubMed Web of Science ®Google Scholar
• Saranath D., Tandle A. T., Teni T. R., Dedhia P. M., Borges A. M., Parikh D. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Oral Oncol. 1999; 35: 242–250
   PubMed Web of Science ®Google Scholar
• Shin D. M., Voravud N., Ro J. Y., Lee J. S., Hong W. K., Hittelman W. N. Sequential increase in proliferating cell nuclear antigen expression in head and neck tumorigenesis, potential marker. J. Natl. Cancer Inst. 1993; 12: 971–978
   Google Scholar
• Slootweg P. J., Koole R., Hordjk G. J. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Oral Oncol. Eur. J. Cancer 1994; Part B: 138–141
   Google Scholar
• Thomas A., Kearsley J. Betel quid and oral cancer: a review. Eur. J. Cancer B Oral Oncol. 1993; 29: 251–255
   Web of Science ®Google Scholar
• Thomas S., Wilson A. A quantitative evaluation of the aetiological role of betel quid in oral carcinogenesis. Eur. J. Cancer B Oral Oncol. 1993; 29: 265–271
   Google Scholar
• van Oijen M G., Gilsing M. M., Rijksen G., Hordijk G. J., Slootweg P. J. Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol. 1998; 34: 297–303
   PubMed Web of Science ®Google Scholar
• Wahlberg I., Ringberger T. Smokeless tobacco. Tobacco: Production, Chemistry and Technology., D. L. Davis, M. T. Nielsen. Blackwell Science, Oxford 1999; 452–460
   Google Scholar
• Warnakulasuriya K. A. A. S., MacDonald D. G. Epithelial cell kinetics in oral leukoplakia. J. Oral Pathol. Med. 1995; 24: 163–169
   Web of Science ®Google Scholar
• Wedenberg C., Jönsson A., Hirsch J. M. Assessment of p53 and Ki-67 expression in snuff induced lesions. Br. J. Oral Maxillofac. Surg. 1996; 34: 409–413
   PubMed Web of Science ®Google Scholar
• Win D. M., Blot W. J., Shy C. M., Pickle L. W., Toledo A., Fraumeni J. F. Snuff dipping and oral cancer among women in the southern United States. N. Engl. J. Med. 1981; 304: 745–749
   PubMed Web of Science ®Google Scholar
• Wood M. W., Medina J. E., Thompson G. C., Houck J. R., Min K. W. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia. Otolarygol. Head Neck Surg. 1994; 111: 758–763
   PubMed Web of Science ®Google Scholar
• Zhang X., Schmitz W., Gelderblom H. R., Reichart P. A. Shammah-induced oral leukoplakia-like lesions. Oral Oncol. 2000; 37: 609–612
   Web of Science ®Google Scholar
• Zoeller J., Flentje M., Sinn P., Born I. A. Evaluation of Agnor and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinoma. Anal Cell Pathol. 1994; 7: 77–88
   PubMed Web of Science ®Google Scholar